Adolfo G Favaretto
- Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II studyAdolfo G Favaretto
Department of Medical Oncology, University Hospital, Padova, Italy
Cancer 97:2791-7. 2003..Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated...
- Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's diseaseSavina M L Aversa
Medical Oncology Department, University Hospital, Padova, Italy
Acta Haematol 112:141-7. 2004..Longer follow-up is necessary to evaluate the extent of all complications...
- Phase II study of pemetrexed plus carboplatin in malignant pleural mesotheliomaGiovanni L Ceresoli
Department of Medical Oncology and Hematology, Istituto Clinico Humanitas Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan, Italy
J Clin Oncol 24:1443-8. 2006..This multicenter, phase II clinical study was conducted to evaluate the activity of the combination of pemetrexed and carboplatin in patients with malignant pleural mesothelioma (MPM)...